Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
Explainer-What are the FLiRT COVID variants and are they more contagious?
Reuters via Yahoo News· 7 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
New approach uses 'cloaked' proteins to deliver cancer-killing therapeutics into cells
Phys.org· 3 days agoThe generalizable technique could lead to repurposing thousands of commercial protein products, including antibodies, for biological research and therapeutic applications. The group's paper, ...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 11 hours agoThe current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still offering solid...
Germany's military to drop mandatory Covid-19 vaccination requirement
dpa international via Yahoo News· 2 days agoSoldiers in the German armed forces will no longer be required to present proof of coronavirus...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 2 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
How to Protect the World from the Next Pandemic | by Winnie Byanyima & Joseph E. Stiglitz - Project...
Project Syndicate· 2 days agoNEW YORK – “History teaches us that the next pandemic is a matter of when, not if,” warned World...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 6 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 6 days agoMcElhaugh’s statement that Arbutus doesn’t anticipate further at-the-market share issuances this year due to its substantial cash balance and liquidity....